Neuron-specific ablation of the Krabbe disease gene galactosylceramidase in mice results in neurodegeneration is a research paper published in PLoS Biology (2022). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Neurological Disorders and Stroke
Grant: NS112327
National Institute of Neurological Disorders and Stroke
Grant: NS106023
National Institute of Neurological Disorders and Stroke
Grant: NS111715
National Institute of Neurological Disorders and Stroke
Grant: NS090835
European Leukodystrophy Association
Grant: ELA-201802314
NINDS NIH HHS
Grant: F30 NS090835
NINDS NIH HHS
Grant: R01 NS112327
NINDS NIH HHS
Grant: R56 NS106023
NINDS NIH HHS
Grant: R01 NS111715
National Institutes of Health
Grant: 5F30NS090835-02
Cell Specific Ablation of GALC and the Pathogenesis of Krabbe Disease
National Institutes of Health
Grant: 5R01NS112327-02
Selective galactosylceramidase ablation to study the pathogenesis of Krabbe leukodystrophy
National Institutes of Health
Grant: 1R56NS106023-01A1
Selective galactosylceramidase ablation to study the pathogenesis of Krabbe leukodystrophy
National Institutes of Health
Grant: 5R01NS111715-05
The Peripheral Nervous System: A Window into Krabbe Disease
FWCI
1.54
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals